NCT03245437View on ClinicalTrials.gov

Target Engagement and Response to Oxytocin

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 4, 2018

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Schizophrenia
Interventions
DRUG

Oxytocin nasal spray

nasal spray

BEHAVIORAL

Social Cognition Skills Training

Group based training in social cognition skills

BEHAVIORAL

Health Management

Group-based training in mental health management

DRUG

Placebo nasal spray

placebo condition

Trial Locations (1)

90073

UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of California, Los Angeles

OTHER

NCT03245437 - Target Engagement and Response to Oxytocin | Biotech Hunter | Biotech Hunter